Dr. Reddys Laboratories Ltd. Board to Consider Final Dividend for FY 2025-26
Dr. Reddys Laboratories Ltd. announced that its Board of Directors will be meeting to consider the proposal regarding the final dividend for the financial year 2025-26.The company noted this consideration in relation to an earlier intimation made on March 23, 2026.
During the board meeting, the directors will consider, inter alia, recommending the final dividend for the fiscal year 2025-26, subject to availability.
DRREDDY Stock Price Movement
Today, Dr. Reddy's Laboratories Limited shares edged higher to close at ₹1221.4, marking a positive close of 0.30% for the session. The equity saw robust institutional interest, trading on a volume of 2.01 million shares.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.